ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium
Open Access
- 10 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (4) , 101185
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM122744)
- National Eye Institute (EY021725)
- University of Oklahoma Health Sciences Center (EY012231, EY019309, EY028949, EY032930, EY032931)
This publication has 43 references indexed in Scilit:
- ADAM-17: the enzyme that does it allCritical Reviews in Biochemistry and Molecular Biology, 2010
- TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β SignalingMolecular Cell, 2009
- Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiencyMicrovascular Research, 2009
- A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteinsBrain Research, 2009
- The ADAMs: signalling scissors in the tumour microenvironmentNature Reviews Cancer, 2008
- Retinopathy in Mice Induced by Disrupted All-trans-retinal ClearanceJournal of Biological Chemistry, 2008
- DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and DegradationJournal of Biological Chemistry, 2008
- Expression of VLDLR in the Retina and Evolution of Subretinal Neovascularization in the Knockout Mouse Model’s Retinal Angiomatous ProliferationInvestigative Ophthalmology & Visual Science, 2008
- Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed stateAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Members of the low density lipoprotein receptor family control diverse physiological processesFrontiers in Bioscience-Landmark, 2001